Skip to search formSkip to main contentSkip to account menu

3-propylamino-5-hydroxychroman

Known as: 5-hydroxy-3-(N-di-n-propylamino)chroman 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Chromans

Narrower (1)

NDO 008

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1989
1989
Decreased 5‐hydroxytryptamine turnover in striatum and other brain regions after administration of 5‐methoxy‐3‐(di‐n‐propylamino)‐chroman to rats
Abstract— 5‐Methoxy‐3‐(di‐n‐propylamino)chroman (5‐MeO‐DPAC) caused a dose‐dependent decrease in the accumulation of 5… 
1988
1988
Effects of the putative 5-HT agonist 5-OH-DPAC on male rat sexual behaviour: a comparison with effects produced by 8-OH-DPAT and buspirone
The new 5-HT agonist 5-hydroxy-3-(di-n-propylamino)chroman (5-OH-DPAC), 0.025-3.2 mg:kg-1, produced a marked facilitation of male… 
1987
1987
The selective labelling of central 5-HT1A receptor binding sites by [3H]5-methoxy-3-(di-n-propylamino)chroman.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)